Drotaverine
Drotaverine hydrochloride
Trade Name:
Product Code:
Active Substance:
Dosage/Volume:
Pharmaceutical Form:
Package:
ATC Classification System:
OTC:
RX:
Product Registration:
Drotaverine – 40 mg / 2 ml Solution for injection
Drotaverine contains the active substance drotaverine hydrochloride. Drotaverine is a derivative of papaverine that possesses antispasmodic activity due to the phosphodiesterase enzyme inhibition in smooth muscles.
Drotaverine is indicated:
• in spastic conditions of smooth muscles related to biliary tract diseases: cholecystolithiasis, cholecystitis;
• in spastic conditions of smooth muscles of urinary tract: nephrolithiasis, pyeitis (pyelonephritis), cystitis, vesical tenesmus;
• as adjunctive drug: in spastic conditions of smooth muscles of the gastrointestinal tract (gastric and duodenal ulcer disease, spastic conditions of cardia and pylorus of stomach, irritable bowel syndrome, spastic constipation, flatulence) and in spastic conditions of the reproductive tract (dysmenorrhea).
ATC CODE:
A03AD02
Shelf life:
36 months
